Spruce Biosciences, Inc. (SPRB) Net income 2019–2025
Spruce Biosciences, Inc. (SPRB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$39.0MFY2025 · since FY2019: -$13.1M → -$39.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.0M | +26.5% |
| FY2024 | -$53.0M | -10.7% |
| FY2023 | -$47.9M | -3.8% |
| FY2022 | -$46.2M | -9.2% |
| FY2021 | -$42.3M | -43.2% |
| FY2020 | -$29.5M | -125.7% |
| FY2019 | -$13.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating marginSPRB Operating cash flowSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →